Assess Build Chem Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.40 Cr
- Company Age 30 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 29.70%
- Profit Growth -58.63%
- Ebitda 284.06%
- Net Worth 9.32%
- Total Assets 13.18%
About Assess Build Chem
Assess Build Chem Private Limited (ABCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 June 1994 and has a history of 30 years and seven months. Its registered office is in Panaji, Goa, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunny Surlaker, Uma Surlaker, and Samir Surlaker serve as directors at the Company.
Company Details
- Location
Panaji, Goa, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909GA1994PTC006208
- Company No.
006208
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 1994
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Who are the key members and board of directors at Assess Build Chem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Surlaker  | Managing Director | 20-Jun-1994 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunny Surlaker | Director | 04-Apr-2023 | Current |
| Uma Surlaker | Director | 20-Jun-1994 | Current |
Financial Performance of Assess Build Chem.
Assess Build Chem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.7% increase. The company also saw a substantial fall in profitability, with a 58.63% decrease in profit. The company's net worth moved up by a moderate rise of 9.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Assess Build Chem?
In 2023, Assess Build Chem had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Assess Sealncare Private LimitedSunny Surlaker, Uma Surlaker and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Assess Build Chem?
Assess Build Chem has a workforce of 17 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Assess Build Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assess Build Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
